Additionally, colchicine has been shown by Robertson et al. to reduce monocyte IL-1β levels in individuals with acute coronary syndrome by reducing pro-caspase-1 and caspase-1 proteins [135]. The gene discussed is CASP1; the disease is acute coronary syndrome.